Clinical Trial Update: A Study of Single-Dose Gabapentin in Subjects With Transient Insomnia Induced by a Sleep Phase Advance [Phase 3]

View source ↗

Summary

Phase 3 study evaluating a single-dose gabapentin for transient insomnia induced by sleep phase advance has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Transient Insomnia

Drugs mentioned

• Gabapentin (Gabapentin)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Transient Insomnia | Phase 3 | Status: COMPLETED